Annual report [Section 13 and 15(d), not S-K Item 405]

Statements of Operations

v3.25.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 12,952,029 7,698,622
General and administrative 3,059,788 1,629,244
Total operating expenses 16,011,817 9,327,866
Loss from operations (16,011,817) (9,327,866)
Interest income 223,008 436,063
Net loss $ (15,788,809) $ (8,891,803)
Per share information:    
Net loss per common share, basic $ (1.21) $ (0.69)
Net loss per common share, diluted $ (1.21) $ (0.69)
Weighted average common shares outstanding, basic 13,014,585 12,848,165
Weighted average common shares outstanding, diluted 13,014,585 12,848,165